Indications
GLOFIL-125 (Sodium Iothalamate I-125 Injection) is indicated for evaluation of glomerular filtration in the diagnosis or monitoring of patients with renal disease.
Contraindications
GLOFIL-125 should not be administered via a central venous line.
Warnings and precautions
None known
Adverse reactions
None Reported
Composition
- Active ingredients
- IOTHALAMATE SODIUM I-125 250-300uCi/ML
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA017279.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Glofil-125
- Active substance
- iothalamate sodium i-125
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Isotex
- Status
- Prescription
- FDA approval
- 12 Feb 1974
- Application
- NDA017279-001